New hope for men with aggressive prostate cancer
NCT ID NCT07311694
Summary
This study is testing whether a new drug called HRS-4357 works better than current standard medications for men with advanced prostate cancer that has spread and stopped responding to hormone therapy. About 370 participants will be randomly assigned to receive either the new drug or one of the standard treatments. The main goal is to see which treatment better delays the cancer from getting worse, as seen on scans.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSMA-POSITIVE PROGRESSIVE METASTATIC CASTRATION-RESISTANT PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fudan University Shanghai Cancer Center
RECRUITINGShanghai, Shanghai Municipality, 201321, China
Contact
Contact
Conditions
Explore the condition pages connected to this study.